![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
Advertisement
Persons > All
Find below all kinds of persons.Total search results: 16845 | Ordered by Person (ascending)
1 2 3 ... 167 168 169 
  Person |
 Position |
Organisation (Group) |
Country |
|---|---|---|---|
| Yusupov, Marat (CNRS 201911 Research Director at IGBMC in Strasbourg) | Researcher (university / research institute) | University of Strasbourg | France |
| Yusupova, Gulnara (CNRS 201911 Research Director at IGBMC in Strasbourg) | Researcher (university / research institute) | University of Strasbourg | France |
| Yver, Antoine (AstraZeneca 201309 VP + Head of Oncology in Global Medicines Development Unit) | President/Director/Head Business Group/Unit/Division | AstraZeneca (Group) | United Kingdom (GB) |
| Yvon, Pascal (S-Biomedic 202208– SVP Commercial Strategy + Sales before Croda Inc) | Sales Manager / Marketing Manager | Beiersdorf (Group) | Belgium |
| Yzer, Cornelia (Berlin (govt) 201305 Senator of Economy, Technology, and Research) | Minister | Berlin (govt region) | Germany |
| Yönel, Mutlu (Prosion 202308 Managing Director (CFO) + Co-Founder) | Chief Financial Officer (CFO) | Prosion GmbH (Prosion Therapeutics) | Germany |
| Zabeau, Marc (Qbic 201202 Managing Partner before Biolign + Methexis + GenScope + Helix + KeyGene) | Managing Partner (investment firm) | Unchained Labs (Group) | Belgium |
| Zabel, Nina (BioRegio STERN 201802–) | Cluster Manager | BioRegio STERN Management GmbH | Germany |
| Zabrowski, Dan (Roche 201202– Head Roche Applied Science before Roche Global Head Pharma Partnering) | President/Director/Head Business Group/Unit/Division | Roche (Group) | United States (USA) |
| Zaby, Andreas (Curacyte 200601) | n. a. | Curacyte (Group) | Germany |
| Zaccagnini, Kiki (Instinctif Partners 202007) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | United Kingdom (GB) |
| Zachardova, Jana (GP Pharma 201503 CEO) | Chief Executive Officer (CEO) | GP Pharm S.A. | Spain (España) |
| Zacharias, Dietmar (Hochschule Bremen 201303 Professor for Applied + Ecological Botanics) | Professor | University of Applied Sciences Bremen (Hochschule Bremen) | Germany |
| Zachert, Matthias (Lanxess 201401– CEO before Merck (DE) CFO) | Chief Executive Officer (CEO) | Lanxess (Group) | Germany |
| Zachmann, Julian (Strüngmann Group 202308 Investment Manager before HTGF) | Investment Manager | STRÜNGMANN Group (family Strüngmann) | Germany |
| Zacho, Helle (Dutscher 202304– CEO of AH Diagnostics joined as CSO in 2017 before Novo Nordisk) | Chief Executive Officer (CEO) | Dutscher (DD) (Group) | Denmark |
| Zacur, Mark (Thermo Fisher 201611 VP + General Manager Healthcare Market Channel) | General Manager (management) | Thermo Fisher (Group) | United States (USA) |
| Zafirakos, Elias (BioPeople (DK) 201404 Science Liaison Officer) | Cluster Manager | Biopeople (Denmark’s Life Science Cluster) | Denmark |
| Zahn, Dorothea (BST Bio Sensor Technology GmbH 201110 Managing Director) | Managing Director | BST Bio Sensor Technologie GmbH | Germany |
| Zahn, Grit (Eternygen GmbH 201309– Head of Research before ipal GmbH + Jerini) | Research & Development Manager | Eternygen (Group) | Germany |
| Zahn, Ralph (Priavoid 201709– Co-Founder formerly Biocrates 201306 CTO) | Chief Technology/Technical Officer (CTO) | Priavoid GmbH | Germany |
| Zahnd, Christian (Molecular Partners 200708 CEO RESIGNED 11/16) | Chief Executive Officer (CEO) | Molecular Partners AG (SIX: MOLN, Nasdaq: MOLN) | Switzerland |
| Zahrádka, Jaromír (i&i 202303 CEO + Partner) | Chief Executive Officer (CEO) | i&i (Group) | Czech Republic |
| Zaichenko, Alexandra (Freelance Consultant + AmeRuss 201505 Director Corporate Strategy) | Business Development Manager / Strategy Manager | BD & Strategic Outsourcing Consultant – Alexandra Zaichenko | Russian Federation |
| Zaimenko, Inna (Versatile Biology Lab 202210 Founder) | Company Founder | Versatile Biology Lab (Inna Zaimenko) | Germany |
| Zairi, Ido (Israel Biotech Fund 202001 Managing Partner + Co-Founder) | Managing Partner (investment firm) | Israel Biotech Fund (IBF) | Israel |
| Zajicek, George (Axis-Shield –200512–200804– BusDev Director before Unipath Ltd + Boehringer Ingelheim) | Business Development Manager / Strategy Manager | Abbott (Group) | United Kingdom (GB) |
| Zakim-Yacouby, Phillip (Cambridge Healthtech Institute 202308 Senior Business Development Manager) | Business Development Manager / Strategy Manager | Cambridge Innovation Institute (Group) | United States (USA) |
| Zakin, Ori (BioRaptor 202210 CEO + Co-Founder) | Chief Executive Officer (CEO) | BioRaptor (IL) | Israel |
| Zakrzewski, Joseph S. (Xcellerex 200705 CEO) | Chief Executive Officer (CEO) | Xcellerex LLC | United States (USA) |
| Zaks, Tal (OrbiMed 202111– Venture Partner before Moderna + Sanofi + SGK) | Venture Partner | OrbiMed (Group) | United States (USA) |
| Zalbidegottia, José María ( Talde Gestión, SGECR S.A. 201504 Chairman) | Managing Director | Talde Gestión, SGECR, S.A. | Spain (España) |
| Zalik, Nir (Evogene 201907 Investor Relations Director) | Public Relations Manager / Investor Relations Manager | Evogene Ltd. (Nasdaq, TASE: EVGN) | Israel |
| Zaman, Naina (Precision Medicine Group 202101 at Stern Investor Relations Inc) | Public Relations Manager / Investor Relations Manager | Precision Medicine Group (Group) | United States (USA) |
| Zambon, Elena (Zambon 201907 President) | Board member | Zambon (Group) | Italy |
| Zambón, Nicola (Cleon Capital 201903 Partner + Founder) | Partner (venture partner) | Cleon Capital fund (ES) | Spain (España) |
| Zamboni, Nicola (ETH Zurich 201007 Institute of Molecular Systems Biology) | Researcher (university / research institute) | ETH Zürich (ETHZ) | Switzerland |
| Zamora, Albert G. (Bionure 201503 CEO) | Chief Executive Officer (CEO) | Bionure (Group) | Spain (España) |
| Zamora, Ismael (Lead Molecular Design 201808 CEO + Scientific Director) | Chief Executive Officer (CEO) | Lead Molecular Design S.L. (LMD) | Spain (España) |
| Zampieri, Gianni (Galenica Group 201702 CEO of Vifor Pharma) | Chief Executive Officer (CEO) | Vifor Pharma (Group) | Switzerland |
| Zanchi, Marta-Gaia (Nina Capital 202011 Founder + Managing Partner) | Partner (venture partner) | Nina Capital SGEIC S.A. | Spain (España) |
| Zang, Jingwu (I-Mab 201711 CEO + Founder of I-Mab Biopharma before GSK RnD China 200705 Head) | Chief Executive Officer (CEO) | GSK (Group) | United Kingdom (GB) |
| Zang, Yuguo (Boehringer 202404 Head of BI BioChina) | President/Director/Head Business Group/Unit/Division | Boehringer Ingelheim (Group) | China |
| Zangvil, Eli (200611 VP BusDev) | Business Development Manager / Strategy Manager | Compugen (Group) | Israel |
| Zanotti, Carlo (Biocross 201503 CEO) | Chief Executive Officer (CEO) | Biocross S.L. | Spain (España) |
| Zanzinger, Johannnes (Boehringer 202001 at BIVF) | Investment Manager | Boehringer Ingelheim (Group) | Germany |
| Zapico, David A. (AMETEK 201608 CEO) | Chief Executive Officer (CEO) | AMETEK (Group) | United States (USA) |
| Zarabozo, Eugenia (AptaTargets 2016– CLO + CFO + Co-Founder) | Chief Financial Officer (CFO) | AptaTargets (ES) | Spain (España) |
| Zarrehparvar, Mazi (MicrobeDx 201701 CEO) | Chief Executive Officer (CEO) | MicrobeDx (Group) | United States (USA) |
| Zaslavets, Pavel (Biopharm-Logos 201405 Business Development Director) | Business Development Manager / Strategy Manager | Biopharm-Logos LLC (RU) | Russian Federation |
| Zauderer, Maurice (Vaccinex 200803 CEO) | Chief Executive Officer (CEO) | Vaccinex Inc. | United States (USA) |
| Zavitsanos, Paul (Agilent 201006 ww Food Program Manager) | n. a. | Agilent (Group) | United States (USA) |
| Zazulina, Victoria (Merck (DE) 202209 Head of Development Unit Oncology before Boehringer Ingelheim) | President/Director/Head Business Group/Unit/Division | Merck (DE) (Group) | Germany |
| Zbar, Brett (General Atlantic 202009– Managing Director + Global Head Life Sciences before Foresite Capital + Aisling) | Managing Director | General Atlantic (Group) | United States (USA) |
| Zbinden, Laurent (MedXCell 202203 CEO) | Chief Executive Officer (CEO) | MedXCell (Group) | Switzerland |
| Zech, Birgit (Anavo Therapeutics 202104 CEO before Gotham Therapeutics + X-Rx + MAB Discovery + Pieris + Axxima) | Chief Executive Officer (CEO) | Anavo Therapeutics (Group) | Netherlands |
| Zechner, Rudolf (Univ Graz 201308 Professor at Instittue for Molecular Biosciences) | Professor | University of Graz (Karl-Franzens-Universität) | Austria |
| Zeevi, Mali (BioLineRx 201610– CFO joined 2009 as Director Finance + Reporting before Tescom Software) | Chief Financial Officer (CFO) | BioLineRx (Group) | Israel |
| Zegger, Ronald (NLC Ventures 202205 Venture Partner) | Venture Partner | NLC Ventures (Group) | Netherlands |
| Zeh, Alexander (Tacalyx 202205 Head of Finance + Administration) | Chief Financial Officer (CFO) | Tacalyx GmbH | Germany |
| Zehethofer, Karl | n. a. | Greiner (Group) | Austria |
| Zehetmayer, Peter (Acquifer Imaging 202301 COO + Director for Sales + Marketing) | Chief Operating Officer (COO) | Bruker (Group) | Germany |
| Zehnder, Alexander (CureVac 202304– CEO before Sanofi + Roche/Genetech) | Chief Executive Officer (CEO) | CureVac (Group) | Germany |
| Zehntner, Heiner (Endress+Hauser 201309 Member of Executive Board) | Board member, executive | Endress+Hauser (Group) | Switzerland |
| Zeidler, Reinhard (Helmholtz 201801 Prof Gene Vectors Research Unit at Helmholtz Zentrum München) | Professor | Helmholtz-Gemeinschaft (HGF) (Group) | Germany |
| Zeifman, Aleksei (RV Invest 202403 Investment Manager) | Investment Manager | RV Invest (VC fund) | |
| Zeilemaker, Sijme (Immunicum 201703– Director Business Development before InteRNA Technologies + to-BBB Technologies) | Business Development Manager / Strategy Manager | Mendus (Group) | Sweden |
| Zeinali, Sirous (Genetek Biopharma 201805 Managing Director + Co-Founder) | Managing Director | Genetek Biopharma GmbH | Germany |
| Zeise, Antje (Epigenomics 201112 Manager IR | PR) | Public Relations Manager / Investor Relations Manager | Epigenomics (Group) | Germany |
| Zeldenrust, Bart (Robeco 200304 Fondsmanager) | Investment Manager | Robeco (Group) | Netherlands |
| Zeldin, Robert K. (Ablynx 201608 CMO) | Chief Medical Officer (CMO) | Sanofi (Group) [since May 2011] | Belgium |
| Zelkovic, Sara (LifeSci 201810 LifeSci Public Relations) | Public Relations Manager / Investor Relations Manager | LifeSci (Group) | United States (USA) |
| Zell, Andreas | n. a. | University of Tübingen (Eberhard-Karls-Universität) | Germany |
| Zeller, Marco (VC Fonds Berlin 200508 Managing Director) | Managing Director | Berlin (govt region) | Germany |
| Zeltner, Jürg (UBS 201604 President of UBS Wealth Management) | President/Director/Head Business Group/Unit/Division | UBS (Group) | Switzerland |
| Zeltz, Patric (BadenBioTec 201104 Managing Director before BF-Biolabs 200312– founder) | Managing Director | BadenBioTec GmbH | Germany |
| Zeltzer, Tal (Phytolon 202009 CTO + Co-Founder) | Chief Technology/Technical Officer (CTO) | Phytolon Ltd. | Israel |
| Zembower, David (deCode chemistry 200512) | n. a. | Amgen (Group) | United States (USA) |
| Zencke, Peter (MeVis Medical Solutions 200708–201106 Supervisory Board Member) | Supervisory Board Member | Varian Medical Systems (Group) | Germany |
| Zenker, Matthias (GAIA 201702 Business Development) | Business Development Manager / Strategy Manager | GAIA AG | Germany |
| Zenker, Othmar (InflaRx 201706– CMO before Head Clinical Research + Development since 2013 before CSL Behring) | Research & Development Manager | InflaRx (Group) | Germany |
| Zenobi, Renato (ETH Zürich 201006 Professor Dept of Chemistry) | Professor | ETH Zürich (ETHZ) | Switzerland |
| Zentgraf, Martin (Desitin 201202 General Manager of Desitin Arzneimittel GmbH) | General Manager (management) | Desitin Arzneimittel GmbH | Germany |
| Zepp, Tobias (CRS Clinical Research Services 201706 Corporate Communications Manager) | Public Relations Manager / Investor Relations Manager | CRS Clinical Research Services (Group) | Germany |
| Zerhouni, Elias A. (Sanofi-Aventis 201101– President Global RnD before NIH Director 2002–2008) | Research & Development Manager | Sanofi (Group) [since May 2011] | France |
| Zerhouni, Peter (InDex Pharmaceuticals 201610 CEO) | Chief Executive Officer (CEO) | InDex Pharmaceuticals (Group) | Sweden |
| Zerrer, Ralf (Clariant 201801 Head Strategic Marketing + Innovation at Business Unit Industrial + Consumer Specialties) | Sales Manager / Marketing Manager | Clariant (Group) | Switzerland |
| Zeskind, Ben (Immuneering 201806 CEO) | Chief Executive Officer (CEO) | Immuneering Corporation | United States (USA) |
| Zettl, Rolf (Combinature co-founder + CEO 200011–200504 afterwards CBO) | Chief Business Officer (CBO) | MerLion (Group) | Germany |
| Zettl, Rolf (Helmholtz 201502 Managing Director) | Managing Director | Helmholtz-Gemeinschaft (HGF) (Group) | Germany |
| Zettl, Sophie (CEBINA 202003 before Arsanis + MedImmune/AZ) | Business Development Manager / Strategy Manager | CEBINA GmbH (Central European Biotech Incubator and Accelerator) | Austria |
| Zettlmeissl, Gerd (Intercell 2005–201105 CEO before COO since 2001 before Chiron Behring before Behringwerke) | Chief Executive Officer (CEO) | Valneva (Group) | Austria |
| Zetzmann-Krien, Diane (Bremen (govt) 201110 Managing Director of Bremer Aubau-Bank GmbH) | Managing Director | Bremen (govt region) | Germany |
| Zeyer, Denis (Novalix 201011 CEO) | Chief Executive Officer (CEO) | Novalix (Group) | France |
| Zeyfang, D. | n. a. | DaimlerChrylser (Group) | Germany |
| Zhang, Feng (MIT 201412 Researcher at Broad Institute) | Researcher (university / research institute) | MIT (Massachusetts Institute of Technology) | United States (USA) |
| Zhang, Ingrid (Novartis 201904 President Novartis Pharmaceuticals China) | President/Director/Head Business Group/Unit/Division | Novartis (Group) | China |
| Zhang, Jay Z. (Shuwen Biotech 201512 CEO) | Chief Executive Officer (CEO) | Shuwen Biotech Co. Ltd. | China |
| Zhang, Lei (Univ Bremen 200603) | n. a. | University of Bremen | Germany |
| Zhang, Long (MindRank 202309 President of China + Co-Founder) | President/Director/Head Business Group/Unit/Division | MindRank (Group) | China |
1 2 3 ... 167 168 169
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
